Stay updated on Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor behind-the-scenes update to the site's revision history.
    Difference
    0.0%
    Check dated 2026-06-05T10:06:12.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision label has been updated to v3.5.4, signaling a newer release of the site. This update does not alter the displayed study details or navigation.
    Difference
    0.0%
    Check dated 2026-05-15T05:34:29.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page metadata shows an interface/release revision bump from v3.5.2 to v3.5.3, with no changes to the underlying ClinicalTrials.gov study content.
    Difference
    0.0%
    Check dated 2026-04-23T21:57:20.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T12:16:24.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Update of the Italy location entry from Padua, Italy, 35128 to Padova, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-09T09:28:58.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Added a new resource entry for Cutaneous neuroendocrine carcinoma under the Genetic and Rare Diseases Information Center resources in the study page.
    Difference
    0.1%
    Check dated 2026-04-02T05:51:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab First-line in Advanced Merkel Cell Carcinoma Clinical Trial page.